A soaring increase in the number of teenagers suffering from diabetes means that more than a third of presumably healthy normal-weight adolescents are at risk of heart disease.

Taking cholesterol-lowering statins following a stroke appears to reduce a patient's chance of dying in the hospital and improves their likelihood of returning home when they are discharged.

It's widely believed that boosting your good HDL cholesterol cuts your risk of a heart attack. A genetic study suggests that might not necessarily be the case.

One of the most common causes of death following a heart transplant is cancer that develops years later. Researchers believe they have found a new strategy for preventing it.

People with Down Syndrome are living longer because of better medical care, but with increasing age, heart disease may become a risk.

Cholesterol-lowering statins , typically prescribed only to patients at elevated risk of heart attack or stroke, also appear to benefit patients with a low risk of suffering adverse heart events.

Most patients are aware that "good" HDL cholesterol can protect against coronary heart disease. However, scientists have found that not all HDL cholesterol benefits the heart, and some may even be harmful.

Drugmaker Roche has halted a pivotal late-stage clinical trial for an experimental medication designed to increase "good" HDL cholesterol after the study revealed it did not offer a benefit.

On top of diet and exercise, medications can help you control your cholesterol. Be careful, though. Some of these medications may pose a threat to your health.

Niacin, also known as vitamin B3 , is the only drug that boosts good HDL cholesterol. Patients commonly stop taking it because of facial flushing, also known as the "niacin flush."